These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin. Burton ME; Chow MS; Platt DR; Day RB; Brater DC; Vasko MR Clin Pharm; 1986 Feb; 5(2):143-9. PubMed ID: 3754192 [TBL] [Abstract][Full Text] [Related]
26. Comparison of a Bayesian program with three microcomputer programs for predicting gentamicin concentrations. Godley PJ; Black JT; Frohna PA; Garrelts JC Ther Drug Monit; 1988; 10(3):287-91. PubMed ID: 3176104 [TBL] [Abstract][Full Text] [Related]
28. Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing. White RH; Hong R; Venook AP; Daschbach MM; Murray W; Mungall DR; Coleman RW J Gen Intern Med; 1987; 2(3):141-8. PubMed ID: 3295148 [TBL] [Abstract][Full Text] [Related]
29. Predicting the daily prothrombin time response to warfarin. Farrow L; Mungall D; Raskob G; Hull R Ther Drug Monit; 1990 May; 12(3):246-9. PubMed ID: 2349607 [TBL] [Abstract][Full Text] [Related]
30. A Bayesian method based on clotting factor activity for the prediction of maintenance warfarin dosage regimens. Pitsiu M; Parker EM; Aarons L; Rowland M Ther Drug Monit; 2003 Feb; 25(1):36-40. PubMed ID: 12548142 [TBL] [Abstract][Full Text] [Related]
31. A model for planning optimal follow-up for outpatients on warfarin anticoagulation. Warfarin Optimal Outpatient Follow-up Study Group. Kent DL; Vermes D; McDonell M; Henikoff J; Fihn SD Med Decis Making; 1992; 12(2):132-41. PubMed ID: 1573980 [TBL] [Abstract][Full Text] [Related]
32. Prospective comparative study of computer programs used for management of warfarin. Poller L; Wright D; Rowlands M J Clin Pathol; 1993 Apr; 46(4):299-303. PubMed ID: 8496384 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of a Bayesian regression program for predicting warfarin response. Boyle DA; Ludden TM; Carter BL; Becker AJ; Taylor JW Ther Drug Monit; 1989; 11(3):276-84. PubMed ID: 2728086 [TBL] [Abstract][Full Text] [Related]
34. The effect of the plasma levels of proteins C and S on the prediction of warfarin maintenance dose requirements. Lubetsky A; Seligsohn U; Ezra D; Halkin H Clin Pharmacol Ther; 1992 Jul; 52(1):42-9. PubMed ID: 1385564 [TBL] [Abstract][Full Text] [Related]
35. Development of a bayesian forecasting method for warfarin dose individualization. Wright DF; Duffull SB Pharm Res; 2011 May; 28(5):1100-11. PubMed ID: 21301936 [TBL] [Abstract][Full Text] [Related]
36. A simple technique for predicting maintenance dosage of warfarin--is it better than empirical dosing? Ovesen L; Lyduch S; Ott P Eur J Clin Pharmacol; 1989; 37(6):573-6. PubMed ID: 2612552 [TBL] [Abstract][Full Text] [Related]
37. Predictive performance of two software packages (USC*PACK PC and Abbott PKS system) for the individualization of amikacin dosage in intensive care unit patients. Gauthier T; Lacarelle B; Marre F; Villard PH; Catalin J; Durand A Int J Biomed Comput; 1994 Jun; 36(1-2):131-4. PubMed ID: 7927852 [TBL] [Abstract][Full Text] [Related]
38. Individualised medicine: why we need Bayesian dosing. Donagher J; Martin JH; Barras MA Intern Med J; 2017 May; 47(5):593-600. PubMed ID: 28503880 [TBL] [Abstract][Full Text] [Related]
39. Pharmacodynamics of warfarin at steady state. Murray B; Coleman R; McWaters D; Ludden T; Mungall D Ther Drug Monit; 1987; 9(1):1-5. PubMed ID: 3576653 [TBL] [Abstract][Full Text] [Related]
40. Prospective evaluation of a flexible protocol for starting treatment with warfarin and predicting its maintenance dose. Cosh DG; Moritz CK; Ashman KJ; Dally RJ; Gallus AS Aust N Z J Med; 1989 Jun; 19(3):191-7. PubMed ID: 2775039 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]